Humanized anti-EGF receptor monoclonal antibody
US7060808B1 · kind B1 · utility
92Cited by
6References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 1996 |
| Grant date | Jun 13, 2006 |
| Priority date | — |
| Expiry date | Jun 7, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A nucleic acid is provided which encodes a humanized antibody or fragment thereof, which encodes a protein which binds to human EGF-receptor. Monoclonal antibody 225 is the complementary determining region (CDR) donor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.